Answers are grounded in this paper and cite their sources.
Finds that higher NK cell percentages may improve outcomes in diffuse large B cell lymphoma, suggesting new treatment strategies.
Patients with higher NK cell percentages may better tolerate chemotherapy-induced depletion, thereby preserving or restoring their effector pool more efficiently. Elevated bone marrow NK cell percentages predict favorable outcomes in DLBCL and support their potential role as translational biomarkers. Incorporating NK cell monitoring into clinical protocols could improve risk stratification and guide immunotherapeutic strategies for personalized patient management.
No takes yet. Share an insight, caveat, or question.
Rincón-López et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: